Company
Halozyme Therapeutics
Halozyme Therapeutics is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.
Latest on Halozyme Therapeutics
- 13F: Harvey Capital Management holds Halozyme Therapeutics ($11M)
- 13F: Steelhead Partners Llc holds Halozyme Therapeutics ($39M)
- 13F: Sidoxia Capital Management Llc holds Halozyme Therapeutics ($3M)
Connections
3 entities linked to Halozyme Therapeutics across the news graph.
Also connected to (3)